The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...
Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company's first-quarter outperformance was ...
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders ...
Step by step, bionic engineers are transforming lives in ways that barely could have been imagined until recently. Our Cover Story is reported now by Barry Petersen: A wheelchair used to be all ...
Advanced Bionics Corp., a medical device company controlled by Los Angeles businessman Alfred E. Mann, agreed Tuesday to be acquired by industry giant Boston Scientific Corp. Based in Valencia, ...
Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should Control Bionics (ASX:CBL) shareholders be worried about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results